pharma · Mantle Cell Lymphoma · Colon cancer
Telethon Foundation
Fondazione Telethon ETS
Telethon Foundation clinical programs — 26 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- roma, IT
- Founded
- 1990
- Employees
- 343
- Programs
- 162
- Drugs
- 285
- Patents
- 0
Telethon Foundation projects
26 ClinicalTrials.gov programs sponsored by Telethon Foundation.
Telethon Foundation has 26 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ALL2820
Fondazione Telethon ETS
Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
1 trial -
Abraxane /ml powder for dispersion for infusion. for metastatic NSCLC patients
Fondazione Telethon ETS
metastatic NSCLC patients
1 trial -
BEVACIZUMAB, ERLOTINIB
Fondazione Telethon ETS
Non-squamous Non-small Cell Lung Cancer
1 trial -
Beyfortus solution for Respiratory Syncytial Virus (RS…
Fondazione Telethon ETS
Respiratory Syncytial Virus (RSV)
1 trial -
CAPECITABINE for Locally advanced stage II/III rectal cancer
Fondazione Telethon ETS
Locally advanced stage II/III rectal cancer
1 trial -
COLECALCIFEROL , PREDNISONE
Fondazione Telethon ETS
Elderly patients with Diffuse Large B-Cell Lymphoma (DLBCL)
1 trial -
D3 (Penta 21)
Fondazione Telethon ETS
HIV-infected
1 trial -
DAUNORUBICIN for Favorable-intermediate-risk Acu…
Fondazione Telethon ETS
Favorable-intermediate-risk Acute Myeloid Leukemia
1 trial -
EMN20
Fondazione Telethon ETS
PATIENTS WITH NEW DIAGNOSIS MULTIPLE MYELOMA WITH AGE >= 65 YEARS OR NOT ELIGIBLE TO ASCT
1 trial -
FIL_FOLL19
Fondazione Telethon ETS
Follicular Lymphoma
1 trial -
FIL_Renoir12
Fondazione Telethon ETS
Follicular lymphoma
1 trial -
FM-17-B01
Fondazione Telethon ETS
Invasive Breast Cancer
1 trial -
GIMEMA AML1919
Fondazione Telethon ETS
Acute Myeloid Leukemia (LMA) with FLT3 mutation
1 trial -
IFOM-CPT0092022PO008
Fondazione Telethon ETS
Colon cancer
1 trial -
Levotiroxina Teva 25 microgrammi compresse
Fondazione Telethon ETS
Hodgkin and non Hodgkin lymphoma, Medulloblastoma
1 trial -
Lynparza film-coated tablets for Recurrent ovarian cancer
Fondazione Telethon ETS
Recurrent ovarian cancer
1 trial -
MDS0519
Fondazione Telethon ETS
Higher-risk-myelodysplastic syndromes
1 trial -
MITO 33
Fondazione Telethon ETS
Recurrent ovarian, fallopian tube or primary peritoneal cancer
1 trial -
Neuraceq 300 MBq/mL solution for injection
Fondazione Telethon ETS
cardiac amyloidosis
1 trial -
OTL-103, OTL-103
Fondazione Telethon ETS
Wiskott-Aldrich syndrome (WAS)
1 trial -
OTL-103-4
Fondazione Telethon ETS
Wiskott-Aldrich Syndrome
1 trial -
PREDNISONE for Idiopathic IgA nephropathy (IgAN)
Fondazione Telethon ETS
Idiopathic IgA nephropathy (IgAN)
1 trial -
REFINE_2020
Fondazione Telethon ETS
Generalized Myasthenia Gravis
1 trial -
The placebo product consists of a soft capsul...
Fondazione Telethon ETS
Prevention of recurrence after a first episode of Venous Thromboembolism (VTE)
1 trial -
Tora-Dol /ml soluzione iniettabile for Patients scheduled for major su…
Fondazione Telethon ETS
Patients scheduled for major surgery for oncologic indication
1 trial -
Vectibix 20 mg/ml concentrate for solution for infusion
Fondazione Telethon ETS
Unresectable left sided RAS/B-RAF wild-type metastatic colorectal cancer
1 trial
Frequently asked questions
How many clinical projects does Telethon Foundation have?
26 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.